Breaking News
Investing Pro 0
Black Friday SALE: Up to 54% OFF InvestingPro+ CLAIM OFFER
Close

Gilead Sciences Inc (GILD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
82.80 +1.17    +1.43%
25/11 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 1,795
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 81.51 - 83.00
Type:  Equity
Market:  Germany
ISIN:  US3755581036 
S/N:  885823
Gilead 82.80 +1.17 +1.43%

GILD Recent Sentiments

 
This page features our users' sentiments regarding the Gilead share. Assess users' predictions on whether they expect Gilead shares to be bearish or bullish.
Start Date Username Call Open Rate End Date Chg. %
Aug 18, 2021 Meister Lampe   62.08 Aug 19, 2021 @ 62.40 +0.52%
Mar 03, 2021 dario reschi   52.14 Mar 26, 2021 @ 55.13 +5.73%
Feb 26, 2021 Max Kreismann   51.51 Mar 19, 2021 @ 54.01 +4.85%
Dec 29, 2020 Network Engineer   46.60 Jan 22, 2021 @ 55.30 +18.67%
Dec 29, 2020 Jan van Tartwijk   46.60 Jan 22, 2021 @ 55.30 -18.67%
Dec 29, 2020 Den Ise   46.28 Jan 22, 2021 @ 55.30 -19.49%
Dec 24, 2020 Finnard Leineweber   47.13 Jan 15, 2021 @ 52.45 +11.29%
Oct 23, 2020 Felipe Rozas   54.25 Nov 13, 2020 @ 51.31 -5.42%
Oct 23, 2020 Ruski Gmnz   55.22 Nov 13, 2020 @ 51.31 -7.08%
Jul 29, 2020 dario reschi   61.98 Aug 21, 2020 @ 56.13 +9.44%
Jul 03, 2020 Tobias König   70.59 Jul 24, 2020 @ 63.12 -10.58%
Jul 03, 2020 Mario Schmidt   69.85 Jul 24, 2020 @ 63.12 -9.63%
Jul 01, 2020 Jan van Tartwijk   70.34 Jul 24, 2020 @ 63.12 -10.26%
Jun 12, 2020 Carmelo Sapienza   65.52 Jul 03, 2020 @ 70.75 +7.98%
Jun 08, 2020 Miguel Sureda Cabrer   70.80 Jul 03, 2020 @ 70.75 -0.07%
Jun 08, 2020 Padraig Crowley   71.52 Jul 03, 2020 @ 70.75 +1.08%
Jun 01, 2020 KEFLIN LAGROSAS   67.63 Jun 26, 2020 @ 66.28 -2.00%
May 28, 2020 Combat Schnecke   67.56 Jun 19, 2020 @ 66.68 -1.30%
May 26, 2020 Tony Lu   69.25 Jun 19, 2020 @ 66.68 -3.71%
May 25, 2020 Philip Mannheimer   69.32 Jun 19, 2020 @ 66.68 -3.81%
May 14, 2020 Hrnning Düsenberg   70.41 May 18, 2020 @ 70.52 +0.16%
May 12, 2020 Carmelo Sapienza   74.89 Jun 05, 2020 @ 68.13 -9.03%
May 07, 2020 Stefan Balster   72.16 May 29, 2020 @ 67.63 -6.28%
May 07, 2020 Stefan Balster   71.50 May 07, 2020 @ 71.50 0.00%
Apr 30, 2020 Combat Schnecke   79.50 May 22, 2020 @ 67.00 -15.72%
Apr 29, 2020 Hermann Albrecht   76.00 May 22, 2020 @ 67.00 -11.84%
Apr 22, 2020 Ana Maria Restrepo...   73.91 May 15, 2020 @ 71.00 -3.94%
Apr 20, 2020 Ramona Kneller   77.02 May 15, 2020 @ 71.00 -7.82%
Apr 17, 2020 Manuela Feichter   83.99 May 08, 2020 @ 71.24 -15.18%
Apr 06, 2020 Hrnning Düsenberg   74.45 Apr 24, 2020 @ 71.41 -4.08%
Mar 20, 2020 Horst Niebling   75.60 Apr 10, 2020 @ 67.09 -11.26%
Mar 16, 2020 Werner Straudi   60.98 Apr 10, 2020 @ 67.09 +10.02%
Feb 28, 2020 clees highland   68.07 Mar 20, 2020 @ 69.00 +1.37%
Feb 24, 2020 Daniel Berndt   67.45 Mar 20, 2020 @ 69.00 +2.30%
Feb 17, 2020 Henry Friedel   63.07 Mar 13, 2020 @ 63.04 -0.05%
Oct 04, 2019 טיראן אברהם   56.69 Oct 25, 2019 @ 56.95 +0.46%
Sep 11, 2019 marco grossi   61.55 Oct 04, 2019 @ 56.68 -7.91%
May 13, 2019 Stefan Ho   56.50 Jun 07, 2019 @ 57.36 +1.52%
Aug 31, 2017 Hermann Albrecht   67.64 Aug 31, 2017 @ 70.16 +3.73%
Aug 31, 2017 Hermann Albrecht   66.99 Aug 31, 2017 @ 68.65 +2.48%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GILD Comments

Write your thoughts about Gilead Sciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oc Masai
Oc Masai Apr 27, 2021 7:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good job GILD. bullish move forward
Ashraf Elgendy
Ashraf Elgendy Mar 07, 2021 13:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Kite, a unit of Gilead Sciences (GILD),has announced that theFDA has granted approval for its T cell immunotherapy Yescarta (axicabtagene ciloleucel) for a certain category of adults...
RM RM
RM RM Mar 01, 2021 21:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Up Again
Ken Laing
Ken Laing Oct 23, 2020 18:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to load up before the big rise coming next week
Iggy Maldon
Iggy Maldon Jul 30, 2020 20:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Classic pump n’ dump. What a shambles
RM RM
RM RM May 28, 2020 22:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will reach above 95
Chili Daug
Chili Daug May 28, 2020 22:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
when? hahah
SAGAR AGARWAL
SAGAR AGARWAL May 15, 2020 14:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good time to accumulate.
Khizer Malik
Khizer Malik May 14, 2020 11:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Gilead will be supplying remdesivir to 127 countries starting next week! Also backed by big government organisations including donald trump. Good investmenr
Willy Chin
Willy Chin Apr 23, 2020 18:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
High chance to be trading above 90, good long stock
Viktor Veselý
Viktor Veselý Apr 12, 2020 7:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
By Deena Beasley(Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc., according to new data based on patient observation.The analysis, published on Friday by the New England Journal of Medicine, does not detail what other treatments the 61 hospitalized patients were given and data on eight of them were not included -- in one case because of a dosing error.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email